Faivre-Finn C, Vicente D, Kurata T, Planchard D, et al. Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial. J Thorac Oncol 2021;16:860-867.
PMID: 33476803